β-arrestin2 in Infiltrated Macrophages Inhibits Excessive Inflammation after Myocardial Infarction
Open Access
- 8 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e68351
Abstract
Beta-arrestins (β-arrestin1 and β-arrestin2) are known as cytosolic proteins that mediate desensitization and internalization of activated G protein-coupled receptors. In addition to these functions, β-arrestins have been found to work as adaptor proteins for intracellular signaling pathways. β-arrestin1 and β-arrestin2 are expressed in the heart and are reported to participate in normal cardiac function. However, the physiological and pathological roles of β-arrestin1/2 in myocardial infarction (MI) have not been examined. Here, we demonstrate that β-arrestin2 negatively regulates inflammatory responses of macrophages recruited to the infarct area. β-arrestin2 knockout (KO) mice have higher mortality than wild-type (WT) mice after MI. In infarcted hearts, β-arrestin2 was strongly expressed in infiltrated macrophages. The production of inflammatory cytokines was enhanced in β-arrestin2 KO mice. In addition, p65 phosphorylation in the macrophages from the infarcted hearts of β-arrestin2 KO mice was increased in comparison to that of WT mice. These results suggest that the infiltrated macrophages of β-arrestin2 KO mice induce excessive inflammation at the infarct area. Furthermore, the inflammation in WT mice transplanted with bone marrow cells of β-arrestin2 KO mice is enhanced by MI, which is similar to that in β-arrestin2 KO mice. In contrast, the inflammation after MI in β-arrestin2 KO mice transplanted with bone marrow cells of WT mice is comparable to that in WT mice transplanted with bone marrow cells of WT mice. In summary, our present study demonstrates that β-arrestin2 of infiltrated macrophages negatively regulates inflammation in infarcted hearts, thereby enhancing inflammation when the β-arrestin2 gene is knocked out. β-arrestin2 plays a protective role in MI-induced inflammation.Keywords
This publication has 35 references indexed in Scilit:
- β-Arrestin-Mediated Signaling Improves the Efficacy of TherapeuticsJournal of Pharmacological Sciences, 2012
- β-Arrestin: A signaling molecule and potential therapeutic target for heart failureJournal of Molecular and Cellular Cardiology, 2011
- G Protein–Dependent and G Protein–Independent Signaling Pathways and Their Impact on Cardiac FunctionCirculation Research, 2011
- Therapeutic potential of β-arrestin- and G protein-biased agonistsTrends in Molecular Medicine, 2011
- β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotectionJournal of Clinical Investigation, 2007
- β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytesProceedings of the National Academy of Sciences, 2006
- Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor–interleukin 1 receptor signalingNature Immunology, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBαProceedings of the National Academy of Sciences, 2004
- Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB PathwaysMolecular Cell, 2004